← Every company

Alnylam Pharmaceuticals Inc SEC Filings

What Alnylam Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

ALNY overview →
Filings on file
128
since Nov 2, 2016
Warning signs
0
none filed
Last results
Jul 30, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Jul 30, 2026
Quarterly report
10-Q
Read ↗
Jul 30, 2026
Results announced
8-K
Read ↗
May 27, 2026
Executive or director changeShareholder vote
8-K
Read ↗
Apr 30, 2026
Quarterly report
10-Q
Read ↗
Apr 30, 2026
Results announced
8-K
Read ↗
Mar 4, 2026
Executive or director change
8-K
Read ↗
Feb 12, 2026
Annual report
10-K
Read ↗
Feb 12, 2026
Results announced
8-K
Read ↗
Jan 12, 2026
Results announced
8-K
Read ↗
Dec 3, 2025
Executive or director change
8-K
Read ↗
Oct 30, 2025
Quarterly report
10-Q
Read ↗
Oct 30, 2025
Results announced
8-K
Read ↗
Oct 3, 2025
Material agreementNew debt
8-K
Read ↗
Sep 12, 2025
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Jul 31, 2025
Quarterly report
10-Q
Read ↗
Jul 31, 2025
Results announced
8-K
Read ↗
Jun 18, 2025
Executive or director change
8-K
Read ↗
May 13, 2025
Shareholder vote
8-K
Read ↗
May 1, 2025
Quarterly report
10-Q
Read ↗
Mar 5, 2025
Executive or director change
8-K
Read ↗
Feb 13, 2025
Annual report
10-K
Read ↗
Jan 13, 2025
Results announced
8-K
Read ↗
Oct 31, 2024
Quarterly report
10-Q
Read ↗
Aug 1, 2024
Quarterly report
10-Q
Read ↗
May 20, 2024
Shareholder vote
8-K
Read ↗
May 2, 2024
Quarterly report
10-Q
Read ↗
Mar 4, 2024
Executive or director change
8-K
Read ↗
Feb 15, 2024
Annual report
10-K
Read ↗
Feb 15, 2024
Results announced
8-K
Read ↗
Jan 19, 2024
Executive or director change
8-K
Read ↗
Jan 8, 2024
Results announced
8-K
Read ↗
Nov 2, 2023
Quarterly report
10-Q
Read ↗
Nov 2, 2023
Results announced
8-K
Read ↗
Sep 28, 2023
Executive or director change
8-K
Read ↗
Aug 3, 2023
Quarterly report
10-Q
Read ↗
Aug 3, 2023
Executive or director changeResults announced
8-K
Read ↗
Jul 26, 2023
Material agreement
8-K
Read ↗
May 23, 2023
Shareholder vote
8-K
Read ↗
May 4, 2023
Quarterly report
10-Q
Read ↗
May 4, 2023
Results announced
8-K
Read ↗
Mar 8, 2023
Executive or director change
8-K
Read ↗
Feb 23, 2023
Annual report
10-K
Read ↗
Feb 23, 2023
Results announced
8-K
Read ↗
Jan 9, 2023
Results announced
8-K
Read ↗
Jan 6, 2023
Executive or director change
8-K
Read ↗
Oct 27, 2022
Quarterly report
10-Q
Read ↗
Oct 27, 2022
Results announced
8-K
Read ↗
Sep 16, 2022
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Aug 24, 2022
Executive or director change
8-K
Read ↗
Jul 28, 2022
Quarterly report
10-Q
Read ↗
Jul 28, 2022
Results announced
8-K
Read ↗
May 23, 2022
Shareholder vote
8-K
Read ↗
Apr 28, 2022
Quarterly report
10-Q
Read ↗
Apr 28, 2022
Results announced
8-K
Read ↗
Apr 5, 2022
Executive or director change
8-K
Read ↗
Feb 10, 2022
Annual report
10-K
Read ↗
Feb 10, 2022
Results announced
8-K
Read ↗
Jan 10, 2022
Results announced
8-K
Read ↗
Jan 4, 2022
Executive or director change
8-K
Read ↗
Dec 20, 2021
Executive or director change
8-K
Read ↗
Oct 28, 2021
Quarterly report
10-Q
Read ↗
Oct 28, 2021
Executive or director changeResults announced
8-K
Read ↗
Sep 8, 2021
Executive or director change
8-K
Read ↗
Aug 3, 2021
Quarterly report
10-Q
Read ↗
Aug 3, 2021
Executive or director changeResults announced
8-K
Read ↗
May 21, 2021
Shareholder vote
8-K
Read ↗
Apr 29, 2021
Quarterly report
10-Q
Read ↗
Apr 29, 2021
Results announced
8-K
Read ↗
Feb 11, 2021
Annual report
10-K
Read ↗
Feb 11, 2021
Results announced
8-K
Read ↗
Jan 11, 2021
Results announced
8-K
Read ↗
Nov 5, 2020
Quarterly report
10-Q
Read ↗
Nov 5, 2020
Results announced
8-K
Read ↗
Oct 2, 2020
Executive or director changeMaterial agreement
8-K
Read ↗
Aug 20, 2020
Material agreement
8-K
Read ↗
Aug 6, 2020
Quarterly report
10-Q
Read ↗
Aug 6, 2020
Executive or director changeResults announced
8-K
Read ↗
May 11, 2020
Shareholder vote
8-K
Read ↗
May 6, 2020
Quarterly report
10-Q
Read ↗
May 6, 2020
Results announced
8-K
Read ↗
Apr 13, 2020
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Apr 6, 2020
Material agreement
8-K
Read ↗
Feb 27, 2020
Executive or director change
8-K
Read ↗
Feb 13, 2020
Annual report
10-K
Read ↗
Feb 6, 2020
Results announced
8-K
Read ↗
Jan 13, 2020
Results announced
8-K
Read ↗
Oct 31, 2019
Quarterly report
10-Q
Read ↗
Oct 31, 2019
Results announced
8-K
Read ↗
Aug 6, 2019
Quarterly report
10-Q
Read ↗
Aug 6, 2019
Results announced
8-K
Read ↗
Jul 11, 2019
Executive or director change
8-K
Read ↗
May 2, 2019
Quarterly report
10-Q
Read ↗
May 1, 2019
Results announced
8-K
Read ↗
Apr 26, 2019
Shareholder vote
8-K
Read ↗
Apr 9, 2019
Material agreementUnregistered share sale
8-K
Read ↗
Feb 14, 2019
Annual report
10-K
Read ↗
Feb 7, 2019
Results announced
8-K
Read ↗
Jan 15, 2019
Material agreement
8-K
Read ↗
Jan 7, 2019
Results announced
8-K
Read ↗
Nov 7, 2018
Quarterly report
10-Q
Read ↗
Nov 7, 2018
Results announced
8-K
Read ↗
Oct 10, 2018
Executive or director change
8-K
Read ↗
Oct 2, 2018
Material agreement
8-K
Read ↗
Aug 17, 2018
Material agreement
8-K
Read ↗
Aug 2, 2018
Quarterly report
10-Q
Read ↗
Aug 2, 2018
Results announced
8-K
Read ↗
May 15, 2018
Executive or director changeShareholder vote
8-K
Read ↗
May 4, 2018
Quarterly report
10-Q
Read ↗
May 3, 2018
Results announced
8-K
Read ↗
Apr 3, 2018
Material agreement
8-K
Read ↗
Mar 14, 2018
Executive or director change
8-K
Read ↗
Feb 15, 2018
Annual report
10-K
Read ↗
Feb 8, 2018
Results announced
8-K
Read ↗
Jan 8, 2018
Results announcedMaterial agreement
8-K
Read ↗
Nov 14, 2017
Material agreement
8-K
Read ↗
Nov 7, 2017
Quarterly report
10-Q
Read ↗
Nov 7, 2017
Results announced
8-K
Read ↗
Aug 9, 2017
Quarterly report
10-Q
Read ↗
Aug 9, 2017
Results announced
8-K
Read ↗
May 25, 2017
Material agreementUnregistered share sale
8-K
Read ↗
May 9, 2017
Executive or director change
8-K
Read ↗
May 5, 2017
Quarterly report
10-Q
Read ↗
May 5, 2017
Results announcedShareholder vote
8-K
Read ↗
Feb 15, 2017
Annual report
10-K
Read ↗
Feb 8, 2017
Results announced
8-K
Read ↗
Jan 3, 2017
Executive or director change
8-K
Read ↗
Nov 3, 2016
Quarterly report
10-Q
Read ↗
Nov 2, 2016
Results announced
8-K
Read ↗

Source: Alnylam Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on ALNY

Related datasets